Sale!

MYF6 Gene Centronuclear Myopathy Type 3 Genetic Test

4,400 د.إ

-21%

The MYF6 gene plays a crucial role in muscle development and function. Mutations in the MYF6 gene can lead to a rare genetic disorder known as Centronuclear Myopathy Type 3 (CNM3), characterized by muscle weakness and structural abnormalities in muscle cells. Identifying mutations in the MYF6 gene is essential for diagnosing CNM3, enabling early intervention and management of the condition.

DNA Labs UAE offers a specialized genetic test aimed at detecting mutations in the MYF6 gene associated with Centronuclear Myopathy Type 3. This test is a vital tool for individuals with a family history of CNM3 or those exhibiting symptoms consistent with the disorder. By analyzing the genetic material with precision, the test can confirm or rule out the presence of the specific mutations linked to this form of myopathy.

The cost of the MYF6 Gene Centronuclear Myopathy Type 3 Genetic Test at DNA Labs UAE is 4400 AED. The testing process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory using advanced genetic sequencing techniques. The results provide valuable information for affected individuals and their families, guiding treatment decisions and genetic counseling.

It’s important for potential test-takers to consult with a healthcare professional or genetic counselor before and after the test to understand the implications of the results and to receive appropriate support and guidance.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

MYF6 Gene Centronuclear Myopathy Type 3 Genetic Test

Centronuclear myopathy type 3 is a rare genetic disorder characterized by muscle weakness and wasting. It is caused by mutations in the MYF6 gene, which is responsible for producing the myogenin protein. The MYF6 Gene Centronuclear myopathy type 3 Genetic Test offered by DNA Labs UAE aims to identify these mutations and confirm a diagnosis.

Test Details

The MYF6 Gene Centronuclear myopathy type 3 Genetic Test is performed using NGS (Next-Generation Sequencing) technology. This advanced sequencing method allows for the analysis of the DNA sequence of the MYF6 gene to identify any changes or mutations.

Test Components and Price

  • Test Name: MYF6 Gene Centronuclear myopathy type 3 Genetic Test
  • Price: 4400.0 AED

Sample Condition

The test requires a blood sample or extracted DNA. Alternatively, one drop of blood can be collected on an FTA card.

Report Delivery

The test results will be delivered within 3 to 4 weeks.

Test Type and Doctor

The MYF6 Gene Centronuclear myopathy type 3 Genetic Test falls under the category of Neurological Disorders. It is recommended to consult a Neurologist for this test.

Test Department

The MYF6 Gene Centronuclear myopathy type 3 Genetic Test is conducted in the Genetics department of DNA Labs UAE.

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient who is undergoing the MYF6 Gene Centronuclear myopathy type 3 NGS Genetic DNA Test. Additionally, a Genetic Counselling session is recommended to draw a pedigree chart of family members affected by MYF6 Gene Centronuclear myopathy type 3.

Signs and Symptoms

Centronuclear myopathy type 3 is characterized by muscle weakness and wasting. Individuals with this disorder may experience difficulties with movement, muscle stiffness, and delayed motor skills development.

Importance of Genetic Testing

The MYF6 Gene Centronuclear myopathy type 3 Genetic Test plays a crucial role in confirming a diagnosis and guiding treatment and management options for individuals with this rare genetic disorder. By identifying mutations in the MYF6 gene, healthcare professionals can provide personalized care and support to patients.

Test Name MYF6 Gene Centronuclear myopathy type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MYF6 Gene Centronuclear myopathy type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MYF6 Gene Centronuclear myopathy type 3
Test Details

The MYF6 gene is associated with centronuclear myopathy type 3, a rare genetic disorder characterized by muscle weakness and wasting. This disorder is caused by mutations in the MYF6 gene, which provides instructions for making a protein called myogenin. Myogenin is important for the development and function of muscle cells.

NGS genetic testing can be used to identify mutations in the MYF6 gene. This type of testing uses advanced sequencing technology to analyze the DNA sequence of the gene and identify any changes or mutations. This information can be used to confirm a diagnosis of centronuclear myopathy type 3 and help guide treatment and management options.